Redeye has updated its near-term estimates following Kontigo Care's Q2 report and maintains a positive view on the case. Recent multi-year municipal wins and Nordic partnerships highlight the scalable potential of its MDR-certified Previct® platform. With the bottom behind it, the company is positioned for growth, with sales expected to accelerate in Q3 and a strong foundation for recurring revenue supported by several near-term potential catalysts.

Läs mer på Redeye

Ämnen i artikeln


Kontigo Care

Senast

2,00

1 dag %

1,53%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån